BR0115296A - Uso de inibidores de recaptação de sorotonina e agonistas de 5ht1a combinados - Google Patents

Uso de inibidores de recaptação de sorotonina e agonistas de 5ht1a combinados

Info

Publication number
BR0115296A
BR0115296A BR0115296-3A BR0115296A BR0115296A BR 0115296 A BR0115296 A BR 0115296A BR 0115296 A BR0115296 A BR 0115296A BR 0115296 A BR0115296 A BR 0115296A
Authority
BR
Brazil
Prior art keywords
combined
sorotonin
reuptake inhibitors
agonists
butyl
Prior art date
Application number
BR0115296-3A
Other languages
English (en)
Inventor
Gerd Bartoszyk
Original Assignee
Merck Patent Ges Mit Beschonkt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Ges Mit Beschonkt filed Critical Merck Patent Ges Mit Beschonkt
Publication of BR0115296A publication Critical patent/BR0115296A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"USO DE INIBIDORES DE RECAPTAçãO DE SOROTONINA E AGONISTAS DE 5-HT~ 1A~ COMBINADOS". A presente invenção refere-se ao uso compostos sendo agonistas receptores de 5-HT~ 1A~ e inibidores de recaptação de sorotonina (5-HT) seletivos (SSRls) combinados, em particular 1-[4-(5-cianoindol-3-il)butil]-4(2-carbamoil-benzofuran-5-il)-piperazina ou um sal famaceuticamente aceitável deste ou 3-{4-[4-(4-ciano-fenil)piperazin-1-il]-butil}-1 H-indol-5-carbonitri-la ou um sal farmaceuticamente aceitável deste, para a preparação de um medicamento para uso na medicina veterinária para o tratamento ou profilaxia de distúrbios traumáticos direcionados a própria pessoa associados com estímulos comportamentais e distúrbios compulsivos associados com estímulos comportamentais.
BR0115296-3A 2000-11-14 2001-10-16 Uso de inibidores de recaptação de sorotonina e agonistas de 5ht1a combinados BR0115296A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00124815 2000-11-14
PCT/EP2001/011952 WO2002040024A1 (en) 2000-11-14 2001-10-16 Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors

Publications (1)

Publication Number Publication Date
BR0115296A true BR0115296A (pt) 2003-09-02

Family

ID=8170369

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0115296-3A BR0115296A (pt) 2000-11-14 2001-10-16 Uso de inibidores de recaptação de sorotonina e agonistas de 5ht1a combinados

Country Status (22)

Country Link
US (1) US20040082594A1 (pt)
EP (1) EP1333832B1 (pt)
JP (1) JP2004513924A (pt)
KR (1) KR20030059244A (pt)
CN (1) CN1222291C (pt)
AR (1) AR031335A1 (pt)
AU (2) AU1502702A (pt)
BR (1) BR0115296A (pt)
CA (1) CA2428511C (pt)
CZ (1) CZ302484B6 (pt)
DE (1) DE60131675T2 (pt)
ES (1) ES2296820T3 (pt)
HK (1) HK1060697A1 (pt)
HU (1) HUP0302751A3 (pt)
MX (1) MXPA03004166A (pt)
NO (1) NO20032148D0 (pt)
PL (1) PL204331B1 (pt)
RU (1) RU2288719C2 (pt)
SK (1) SK287337B6 (pt)
UA (1) UA79583C2 (pt)
WO (1) WO2002040024A1 (pt)
ZA (1) ZA200304606B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10305739A1 (de) * 2003-02-11 2004-08-19 Merck Patent Gmbh Benzofuranderivate
WO2005061455A1 (en) 2003-12-23 2005-07-07 H. Lundbeck A/S 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri
EP1732610A2 (en) 2004-03-26 2006-12-20 Baylor University Targeted serotonin reuptake inhibitors
AR052308A1 (es) 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto
WO2006034788A1 (en) * 2004-09-28 2006-04-06 Merck Patent Gmbh Combinations of n-(indolecarbonyl-)piperazine derivatives and serotonin reuptake inhibitors
AR054393A1 (es) 2005-06-17 2007-06-20 Lundbeck & Co As H Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos.
US7629473B2 (en) 2005-06-17 2009-12-08 H. Lundbeck A/S 2-(1H-indolylsulfanyl)-aryl amine derivatives
CN101563080A (zh) * 2006-08-11 2009-10-21 帝斯曼知识产权资产管理有限公司 用于治疗中枢神经病症的藁本内酯衍生物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4333254A1 (de) * 1993-09-30 1995-04-06 Merck Patent Gmbh Piperidine und Piperazine
DE19512639A1 (de) * 1995-04-05 1996-10-10 Merck Patent Gmbh Benzonitrile und -fluoride
DE19637237A1 (de) * 1996-09-13 1998-03-19 Merck Patent Gmbh Piperazin-Derivate
DE19730989A1 (de) * 1997-07-18 1999-01-21 Merck Patent Gmbh Piperazin-Derivate
AU5033899A (en) * 1998-07-20 2000-02-14 Merck Patent Gmbh Biphenyl derivatives

Also Published As

Publication number Publication date
EP1333832B1 (en) 2007-11-28
CA2428511C (en) 2009-12-29
RU2288719C2 (ru) 2006-12-10
CZ20031433A3 (cs) 2003-09-17
CA2428511A1 (en) 2002-05-23
AR031335A1 (es) 2003-09-17
HK1060697A1 (en) 2004-08-20
CN1222291C (zh) 2005-10-12
HUP0302751A3 (en) 2007-06-28
SK6382003A3 (en) 2003-11-04
JP2004513924A (ja) 2004-05-13
PL360310A1 (en) 2004-09-06
AU2002215027B2 (en) 2006-10-05
HUP0302751A2 (hu) 2003-11-28
CZ302484B6 (cs) 2011-06-08
EP1333832A1 (en) 2003-08-13
DE60131675T2 (de) 2008-11-20
CN1474691A (zh) 2004-02-11
AU1502702A (en) 2002-05-27
SK287337B6 (sk) 2010-07-07
WO2002040024A1 (en) 2002-05-23
ZA200304606B (en) 2004-09-13
NO20032148L (no) 2003-05-13
US20040082594A1 (en) 2004-04-29
KR20030059244A (ko) 2003-07-07
MXPA03004166A (es) 2003-09-22
ES2296820T3 (es) 2008-05-01
DE60131675D1 (de) 2008-01-10
NO20032148D0 (no) 2003-05-13
PL204331B1 (pl) 2010-01-29
UA79583C2 (en) 2007-07-10

Similar Documents

Publication Publication Date Title
DK0619805T3 (da) 5-(Hetero-eller carbocyclylamino)-indolderivater, deres fremstilling og anvendelse som 5-HT1-agonister
BR0212586A (pt) Composição, uso de uma combinação de ipratrópio ou um sal deste e de xilometazolina ou um sal desta, e, métodos para o tratamento de uma condição selecionada ao grupo que consiste de sintomas associados com o resfriado comum e sintomas associaods com a rinite e para estabilizar uma solução aquosa de ipratrópio ou um sal deste e xilometazolina ou um sal desta
Minashima et al. Lithium protects against cartilage degradation in osteoarthritis
NO20093464L (no) Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika
BR0315681A (pt) Composto e seus sais e hidratos farmaceuticamente aceitáveis, composição farmacêutica, métodos para o tratamento de doenças mediadas pela prostaglandina d2, para o tratamento de congestão nasal, para o tratamento de asma alérgica, e para o tratamento de rinite alérgica, composto ou um seu sal ou solvato farmaceuticamente aceitável, sal ou hidrato do composto, e, uso de um composto ou de um seu sal ou solvato farmaceuticamente aceitável
TR200201004T2 (tr) Monoamin reuptake önleyicileri olarak biaril eter türevleri
NO20032111L (no) Nye medikamentblandinger basert pa tiotropium-salter og pa salmeterol-salter
BR0116505A (pt) Compostos ou um sal deste farmaceuticamente aceitável, composições farmacêuticas, método para tratar ou prevenir doenças ou distúrbios onde um antagonista de um receptor de orexina humano é requerido, e, processo para a fabricação de composições farmacêuticas para o tratamento de distúrbios associados com o papel da orexina, especialmente da obesidade e distúrbios do sono
BR0114754A (pt) Compostos não-imidazóis
NZ525700A (en) Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5HT-2 receptor
IL165264A (en) Protein kinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating protein kinase-associated diseases
BRPI0108977B8 (pt) compostos azacíclicos, composição farmacêutica e uso de um composto ou sal farmaceuticamente aceitável do mesmo
BRPI0407253A (pt) Heterociclil-3-sulfonilindazóis como ligandos 5-hidroxitriptamina-6 processo de preparação dos mesmos, seus usos na preparação de uma composição farmacêutica e composição farmacêutica compreendendo os referidos compostos
HRP20050103B1 (hr) N-aril supstituirani bifenilkarboksamidi kao inhibitori sekrecije apolipoproteina b
BRPI0411936A (pt) composto, processo para a sua preparação, composição farmacêutica que comprende o mesmo, utilização de um composto, métodos para o tratamento e profilaxia de distúrbios do sistema nervoso central, alimentares e obesidade
CY1108061T1 (el) Παραγωγα κιναζολινης ως src αναστολεις κινασης τυροσινης
BR0115296A (pt) Uso de inibidores de recaptação de sorotonina e agonistas de 5ht1a combinados
BRPI0413584A (pt) composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento de doenças e para tratamento de um distúrbio no sistema nervoso central
BR0206237A (pt) Uso de um composto de carboestiril
HUP0204285A2 (en) Pharmaceutical composition containing 6-hydroxi-8-{4-[4-(2-pyrimidinyl)piperazinyl]-butyl}-8-azaspiro[4.5]-7.9-dione and improved process alleviation of anxiety
SE9902267D0 (sv) New compounds
RU2003115431A (ru) Новые применения объединенных агонистов 5-нт1а и ингибиторов обратного захвата серотонина
PE20030236A1 (es) Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados
ATE342720T1 (de) Kombination aus quetiapin und zolmitriptan
NO308001B1 (no) Nye kromenforbindelser, deres anvendelse for fremstilling av et preparat samt farmasøytisk sammensetning inneholdende kromenforbindelser

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.